Recombinant antibodies (rAbs), also known as genetically engineered antibodies, are generated by cloning of the antibody heavy and light chain DNA sequences.
Compared to monoclonal antibodies produced using traditional hybridoma techniques, recombinant antibodies offer advantages, such as high lot-to-lot consistency, animal-free manufacturing, engineering advancement possibilities, and continuous supply. Given the importance, recombinant antibodies are becoming indispensable tools for basic research, diagnostics, and clinical applications.
Download this app note to learn more about the formats, expressions, and applications of these recombinant antibodies:
Brought to you by